Question 1

What is the catalog number for LY-3475070?

Accepted Answer

The catalog number for LY-3475070 is M24092.

Question 2

What sizes are available for LY-3475070?

Accepted Answer

LY-3475070 is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does LY-3475070 come in?

Accepted Answer

LY-3475070 is available in 8 different pack sizes.

Question 4

Is LY-3475070 in stock?

Accepted Answer

LY-3475070 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is LY-3475070 used for?

Accepted Answer

LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.

Question 6

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 8

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

LY-3475070

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

PROTAC BTK Degrader-6

PROTAC BTK Degrader-6

PROTAC BTK Degrader-6

PROTAC BTK Degrader-6

Anti-new delhi metallo-β-lactamase (NDM), Mouse mAb

Anti-new delhi metallo-β-lactamase (NDM), Mouse mAb